-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|March 14, 2025

Key Benefits of CGM Technology

Author(s)Davida Kruger, MSN, APN-BC, BC-ADM , Jaime Murillo, MD, FACC, FASE , Ian Neeland, MD, FAHA, FACC

This program was supported through an independent medical education grant from Dexcom Medical Affairs. Experts discuss the key benefits of continuous glucose monitoring (CGM) technology compared with traditional monitoring based on recent clinical trial data, including research on cardiovascular risk reduction in noninsulin-treated T2D.

Episodes in this series

1 KOL is featured in this series.

EP. 1 CGM: Redefining Type 2 Diabetes Management

EP. 2 Key Benefits of CGM Technology

EP. 2 Key Benefits of CGM Technology

EP. 3 CGM's Impact on Clinical Inertia

EP. 3 CGM's Impact on Clinical Inertia

EP. 4 CGM vs Traditional Monitoring

EP. 4 CGM vs Traditional Monitoring

EP. 5 Understanding CGM Metrics

EP. 5 Understanding CGM Metrics

EP. 6 Health Care System Integration

EP. 6 Health Care System Integration

EP. 7 CGM Coverage and Access

EP. 7 CGM Coverage and Access

EP. 8 Implementation Barriers

EP. 8 Implementation Barriers

EP. 9 Overcoming Access Challenges

EP. 9 Overcoming Access Challenges

EP. 10 Adoption Strategies

EP. 10 Adoption Strategies

EP. 11 The Metro Nashville Public Schools Initiative

EP. 11 The Metro Nashville Public Schools Initiative

EP. 12 Health Care Quality Impact

EP. 12 Health Care Quality Impact

EP. 13 Population Outcomes and Return on Value With CGMs

EP. 13 Population Outcomes and Return on Value With CGMs

EP. 14 Long-Term Outcomes Assessment

EP. 14 Long-Term Outcomes Assessment

EP. 15 Closing Perspectives

EP. 15 Closing Perspectives

Video content above is prompted by the following:

Based on recent clinical trial data, including your research on cardiovascular-risk reduction in noninsulin patients, what are the key benefits of CGM technology compared with traditional monitoring?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Health Equity & Access Weekly Roundup

Health Equity & Access Weekly Roundup: July 10, 2026

ByGiuliana Grossi

July 10th 2026

Stefanie Houseknecht, PharmD | Image Credit: LinkedIn

Pharmacists Help Navigate Precision Lung Cancer Care: Stefanie Houseknecht, PharmD

BySabrina McCrear,Stefanie Houseknecht, PharmD

July 10th 2026

Risk Stratification and Weight Loss as Therapy: A Hepatologist's Framework for Managing MASH Progression

ByNadege Gunn, MD

July 10th 2026

Screening MASH Upstream: Building a Practical, Scalable Algorithm for the Real World

ByNadege Gunn, MD

July 10th 2026

Dr Cherie Daley | Image Credit: PCRF

Pediatric Cancer Creates Long-Term Financial Challenges for Patients, Families: Cherie Daly, MD

ByBrooke McCormick,Cherie Daly, MD

July 9th 2026

Trending on AJMC

Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues

INCA033989 May Address Unmet Need in Mutant Calreticulin Myelofibrosis: Claire Harrison, MD

Kerry Rogers, MD, on BTK Inhibitor Selection and Tolerability in CLL

FDA Expands Pembrolizumab-Enfortumab for Muscle-Invasive Bladder Cancer

FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma